Sensor-Integrated Airway Stent Enables Continuous Remote Monitoring

Surveillance often relies on intermittent bronchoscopy, which requires anesthesia and carries procedural risk. Missed early changes can lead to respiratory compromise and unplanned hospital care. To help address this challenge, researchers have developed a chip‑free, battery‑free airway stent that enables continuous remote monitoring.

Developed at Vanderbilt University (Nashville, TN, USA), the technology integrates sensing capability directly into an airway stent for patients with diseases such as lung cancer. The approach is designed to extend monitoring beyond the procedure suite and into daily life. The device is a sensory airway stent that incorporates multiple sensors and a miniature, magnetically controlled switch. It enables wireless, minimally invasive monitoring of deep airway physiology outside the hospital. The system is intended to detect early physiologic changes that precede clinically significant complications.

According to the research team, the platform can track indicators such as tissue stiffness, pressure, mucus accumulation, and temperature. By providing longitudinal data streams rather than intermittent snapshots, it is intended to alert clinicians to evolving problems earlier in the course. This capability could reduce reliance on repeat bronchoscopies and support timely, targeted interventions when stent dysfunction begins to emerge.

Early validation focused on material compatibility. An in vitro study demonstrated strong biocompatibility of the sensory airway stent. The work was published in Science Advances on April 15, 2026, and involved collaborators from Vanderbilt University, Vanderbilt University Medical Center, and Texas A&M University.

“This chip-free and battery-free framework enables continuous, noninvasive, and early detection of complications, reducing the need for frequent bronchoscopies and improving patient outcome. Such a system also provides clinicians with longitudinal data to guide timely interventions and optimize treatment,” said Xiaoguang Dong, assistant professor of mechanical engineering, biomedical engineering, and electrical and computer engineering at Vanderbilt University.

“As a thoracic and lung transplant surgeon, I see firsthand how limited we are by intermittent, invasive monitoring of airway stents. This technology offers a transformative shift, enabling continuous, remote assessment of airway physiology so we can detect complications earlier and intervene before they become clinically significant,” said Caitlin Demarest, assistant professor of Thoracic Surgery in the Vanderbilt School of Medicine.

Related Links
Vanderbilt University